These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35589252)

  • 21. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
    China L; Freemantle N; Forrest E; Kallis Y; Ryder SD; Wright G; Portal AJ; Becares Salles N; Gilroy DW; O'Brien A;
    N Engl J Med; 2021 Mar; 384(9):808-817. PubMed ID: 33657293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial.
    Romanelli RG; La Villa G; Barletta G; Vizzutti F; Lanini F; Arena U; Boddi V; Tarquini R; Pantaleo P; Gentilini P; Laffi G
    World J Gastroenterol; 2006 Mar; 12(9):1403-7. PubMed ID: 16552809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
    Solà E; Solé C; Simón-Talero M; Martín-Llahí M; Castellote J; Garcia-Martínez R; Moreira R; Torrens M; Márquez F; Fabrellas N; de Prada G; Huelin P; Lopez Benaiges E; Ventura M; Manríquez M; Nazar A; Ariza X; Suñé P; Graupera I; Pose E; Colmenero J; Pavesi M; Guevara M; Navasa M; Xiol X; Córdoba J; Vargas V; Ginès P
    J Hepatol; 2018 Dec; 69(6):1250-1259. PubMed ID: 30138685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolvaptan reduces the required amount of albumin infusion in patients with decompensated cirrhosis with uncontrolled ascites : a multicenter retrospective propensity score-matched cohort study.
    Suzuki Y; Naganuma A; Hoshino T; Hatanaka T; Ueno T; Namikawa M; Takizawa D; Arai H; Suzuki H; Takagi H; Tojima H; Yamazaki Y; Sato K; Kakizaki S; Uraoka T
    Acta Gastroenterol Belg; 2021; 84(1):57-63. PubMed ID: 33639694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of human albumin for the treatment of ascites in patients with liver cirrhosis: item of safety, facts, controversies and perspectives.
    Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Longo N; Panella C; Ierardi E
    Curr Drug Saf; 2011 Sep; 6(4):267-74. PubMed ID: 22129322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Albumin: Indications in chronic liver disease.
    Tufoni M; Zaccherini G; Caraceni P; Bernardi M
    United European Gastroenterol J; 2020 Jun; 8(5):528-535. PubMed ID: 32213034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites.
    McCormick PA; Mistry P; Kaye G; Burroughs AK; McIntyre N
    Gut; 1990 Feb; 31(2):204-7. PubMed ID: 2311979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A meta-analysis of the efficacy and safety of human serum albumin treatment in patients with ascites due to cirrhosis undergoing drainage.
    Zheng YJ; Zhuo SJ; Huang B; Su S
    Asian J Surg; 2021 Aug; 44(8):1116-1117. PubMed ID: 34148750
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term albumin administration in patients with decompensated cirrhosis. It is time for a reappraisal.
    Bañares R; Bernardi M
    Liver Int; 2019 Jan; 39(1):45-48. PubMed ID: 30576080
    [No Abstract]   [Full Text] [Related]  

  • 31. Current indications for the use of albumin in the treatment of cirrhosis.
    Alves de Mattos A
    Ann Hepatol; 2011 May; 10 Suppl 1():S15-20. PubMed ID: 21566250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical indications for the albumin use: still a controversial issue.
    Caraceni P; Domenicali M; Tovoli A; Napoli L; Ricci CS; Tufoni M; Bernardi M
    Eur J Intern Med; 2013 Dec; 24(8):721-8. PubMed ID: 23790570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albumin infusion in liver cirrhotic patients.
    Rena NM; Wibawa ID
    Acta Med Indones; 2010 Jul; 42(3):162-8. PubMed ID: 20724771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indications for chronic albumin infusion.
    Perkins JD
    Liver Transpl; 2006 Feb; 12(2):320-1. PubMed ID: 16447190
    [No Abstract]   [Full Text] [Related]  

  • 35. The role and indications of albumin in advanced liver disease.
    Zaccherini G; Bernardi M
    Acta Gastroenterol Belg; 2019; 82(2):301-308. PubMed ID: 31314192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure.
    Mirici-Cappa F; Caraceni P; Domenicali M; Gelonesi E; Benazzi B; Zaccherini G; Trevisani F; Puggioli C; Bernardi M
    World J Gastroenterol; 2011 Aug; 17(30):3479-86. PubMed ID: 21941414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
    El-Sherif O; Jiang ZG; Tapper EB; Huang KC; Zhong A; Osinusi A; Charlton M; Manns M; Afdhal NH; Mukamal K; McHutchison J; Brainard DM; Terrault N; Curry MP
    Gastroenterology; 2018 Jun; 154(8):2111-2121.e8. PubMed ID: 29535028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study.
    Yosry A; Soliman ZA; Eletreby R; Hamza I; Ismail A; Elkady MA
    Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):345-351. PubMed ID: 30312183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic albumin infusions to achieve diuresis in patients with ascites who are not candidates for transjugular intrahepatic portosystemic shunt (TIPS).
    Trotter J; Pieramici E; Everson GT
    Dig Dis Sci; 2005 Jul; 50(7):1356-60. PubMed ID: 16047487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined furosemide and human albumin treatment for diuretic-resistant edema.
    Elwell RJ; Spencer AP; Eisele G
    Ann Pharmacother; 2003 May; 37(5):695-700. PubMed ID: 12708949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.